MDL 104903 | 180799-56-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: MDL 104903
• 英文别名: benzyl N-[(2S)-1-[(4S,5R)-4-benzyl-5-hydroxy-1,3-oxazolidin-3-yl]-3-methyl-1-oxobutan-2-yl]carbamate
• CAS: 180799-56-8
• 化学式: C₂₃H₂₈N₂O₅
• 分子量: 412.486
• InChiKey: RQJMBUCEYHNCIW-JAXLGGSGSA-N

物化性质

• 沸点：
  628.2±55.0 °C(Predicted)
• 密度：
  1.236±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  30
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  88.1
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  乙酰氯 、 MDL 104903 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以73%的产率得到MDL 104860
  参考文献：
  名称：

  Hydroxyoxazolidines as α-aminoacetaldehyde equivalents: Novel inhibitors of calpain

  摘要：

  The synthesis of [1-[(5-hydroxy-4-(phenylmethyl)-3-oxazolidinyl)carbonyl]-2-ethylpropyl] carbamic acid phenylmethyl ester (2; MDL 104,903), a potent inhibitor of calpain, is described. Synthesis of related compounds, which offer insights into the mechanism of action for 2, are also described, as is an O-acetyl prodrug derivative of 2. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00391-1
• 作为产物：
  描述：

  N-苄氧羰基-缬氨酰-苯基丙氨酸甲酯 在 二异丁基氢化铝 、 对甲苯磺酸 作用下， 以 甲苯 、 苯 为溶剂， 生成 MDL 104903
  参考文献：
  名称：

  Hydroxyoxazolidines as α-aminoacetaldehyde equivalents: Novel inhibitors of calpain

  摘要：

  The synthesis of [1-[(5-hydroxy-4-(phenylmethyl)-3-oxazolidinyl)carbonyl]-2-ethylpropyl] carbamic acid phenylmethyl ester (2; MDL 104,903), a potent inhibitor of calpain, is described. Synthesis of related compounds, which offer insights into the mechanism of action for 2, are also described, as is an O-acetyl prodrug derivative of 2. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00391-1

文献信息

• Polynucleotide encoding a novel cysteine protease of the calpain superfamily, Protease-42
  申请人：——

  公开号：US20040014093A1

  公开（公告）日：2004-01-22

  The present invention provides novel polynucleotides encoding Protease-42 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel Protease-42 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
• Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof
  申请人：Chen Jian

  公开号：US20060183196A1

  公开（公告）日：2006-08-17

  The present invention provides novel polynucleotides encoding CAN-12 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants of CAN-12 polypeptides, CAN-12v1 and CAN-12v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel CAN-12, CAN-12v1, and CAN-12v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly neuro- and musculo-degenerative conditions. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
• [EN] DIABETES AND METABOLIC SYNDROME THERAPY UTILIZING CATHEPSIN B INHIBITORS<br/>[FR] TRAITEMENT DU DIABETE ET DU SYNDROME METABOLIQUE AU MOYEN D'INHIBITEURS DE LA CATHEPSINE B
  申请人：AXYS PHARM INC

  公开号：WO2005097103A2

  公开（公告）日：2005-10-20

  The present invention is directed to the treatment of Type II diabetes by administering a cathepsin B inhibitor(s).
• Hydroxyoxazolidines as α-aminoacetaldehyde equivalents: Novel inhibitors of calpain
  作者：Norton P. Peet、Hwa-Ok Kim、Angela L. Marquart、Michael R. Angelastro、Thaddeus R. Nieduzak、Julie N. White、Dirk Friedrich、Gary A. Flynn、Mark E. Webster、Roy J. Vaz、Matthew D. Linnik、Jack R. Koehl、Shujaath Mehdi、Philippe Bey、Bart Emary、Kin-Kai Hwang

  DOI：10.1016/s0960-894x(99)00391-1

  日期：1999.8

  The synthesis of [1-[(5-hydroxy-4-(phenylmethyl)-3-oxazolidinyl)carbonyl]-2-ethylpropyl] carbamic acid phenylmethyl ester (2; MDL 104,903), a potent inhibitor of calpain, is described. Synthesis of related compounds, which offer insights into the mechanism of action for 2, are also described, as is an O-acetyl prodrug derivative of 2. (C) 1999 Elsevier Science Ltd. All rights reserved.